Hong 2013.

Study name	NCT00846508 Cisplatin‐based chemoradiation versus radiotherapy for cervical cancer and with a clinically‐defined good prognosis.
Methods	Single‐blind RCT.
Participants	208 women with stage IB ‐ IIB cervical cancer who have no LN or systemic metastases.
Interventions	Arm 1: Primary radiotherapy Arm 2: radiotherapy plus 6 x weekly cisplatin (40 mg/m²)
Outcomes	Primary: survival and toxicity. Secondary: molecular markers associated with radiosensitivity and distant metastases.
Starting date	February 2009; recruiting.
Contact information	Ji‐Hong Hong, Department of Radiation Oncology, LIN KOU Chang Gung memorial Hospital, Taiwan
Notes